Use of Maslinic Acid for the Treatment of Diseases and the Symptoms Thereof By Means of Cox-2 Inhibition

The invention relates to the use of maslinic acid or natural, synthetic or semi-synthetic maslinic-rich mixtures or of a composition containing said acid for the treatment of pathological processes associated with COX-2 activation, intended, inter alia, for the symptomatic and/or regenerative treatment of arthrosis, rheumatoid arthritis, fibromyalgia, sciatica and other articular disorders that are difficult to diagnose. The invention also relates to the topical administration thereof.

Patents:
WO 2,009,121,992

Inventor(s): PRADOS OSUNA JOSE [ES]; GARCIA-GRANADOS LOPEZ DE HIERRO ANDRES [ES]; PARRA SANCHEZ ANDRES [ES]; MARTINEZ RODRIGUEZ ANTONIO [ES]

Type of Offer: Sale



« More Medical Patents

---